Search research articles
Contact Us
Filters
Showing results (101-110 of 150) with videos related to
Page
of 15
Sort By:
Journal for Immunotherapy of Cancer
|
March 25, 2026
Telmisartan increases olaparib efficacy in homologous recombination proficient tumors by augmenting type I interferon production
Clare E Murray, Carlos O Ontiveros, Jordan Wentworth, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
May 29, 2012
Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha
Bridgette M Collins-Burow, James W Antoon, Daniel E Frigo, et al.
Autophagy
|
July 4, 2014
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors
Devalingam Mahalingam, Monica Mita, John Sarantopoulos, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 28, 2013
eRapa restores a normal life span in a FAP mouse model
Paul Hasty, Carolina B Livi, Sherry G Dodds, et al.
Cancer Research
|
February 8, 2005
CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers
Ilona Kryczek, Andrzej Lange, Peter Mottram, et al.
Aging Cell
|
August 29, 2015
Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice
Vincent Hurez, Vinh Dao, Aijie Liu, et al.
Oncoimmunology
|
August 16, 2019
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial
Niannian Ji, Neelam Mukherjee, Edwin E Morales, et al.
Cancer Research
|
February 17, 2017
Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors
Shannon M Steinberg, Tamer B Shabaneh, Peisheng Zhang, et al.
Cancer Research
|
September 19, 2020
CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade
Justin M Drerup, Yilun Deng, Sri Lakshmi Pandeswara, et al.
Nature Medicine
|
December 1, 2001
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells
W Zou, V Machelon, A Coulomb-L'Hermin, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 150) with videos related to
Sort By:
Page
of 15
Journal for Immunotherapy of Cancer
|
March 25, 2026
Telmisartan increases olaparib efficacy in homologous recombination proficient tumors by augmenting type I interferon production
Clare E Murray, Carlos O Ontiveros, Jordan Wentworth, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
May 29, 2012
Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha
Bridgette M Collins-Burow, James W Antoon, Daniel E Frigo, et al.
Autophagy
|
July 4, 2014
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors
Devalingam Mahalingam, Monica Mita, John Sarantopoulos, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 28, 2013
eRapa restores a normal life span in a FAP mouse model
Paul Hasty, Carolina B Livi, Sherry G Dodds, et al.
Cancer Research
|
February 8, 2005
CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers
Ilona Kryczek, Andrzej Lange, Peter Mottram, et al.
Aging Cell
|
August 29, 2015
Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice
Vincent Hurez, Vinh Dao, Aijie Liu, et al.
Oncoimmunology
|
August 16, 2019
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial
Niannian Ji, Neelam Mukherjee, Edwin E Morales, et al.
Cancer Research
|
February 17, 2017
Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors
Shannon M Steinberg, Tamer B Shabaneh, Peisheng Zhang, et al.
Cancer Research
|
September 19, 2020
CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade
Justin M Drerup, Yilun Deng, Sri Lakshmi Pandeswara, et al.
Nature Medicine
|
December 1, 2001
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells
W Zou, V Machelon, A Coulomb-L'Hermin, et al.
Page
of 15